Aegros Bidco to acquire Alliance Pharma in £362 million deal
LONDON: On 10 January 2025, Aegros Bidco Limited and Alliance Pharma plc announced a recommended acquisition of Alliance by Bidco, excluding shares held by DBAY Advisors Limited. The deal, valued at approximately £362 million, will be executed through a Court-sanctioned scheme under the Companies Act. On 31 January 2025, Alliance published a Scheme Document outlining…